The National Pharmaceutical Pricing Authority (NPPA) has released revised Maximum Retail Prices (MRPs) for 543 brands of anti-cancer medicines, with the new prices scheduled to take effect from November 9, 2026.
According to information shared by the Ministry of Chemicals and Fertilizers, several key brands of anti-cancer medicines have recorded significant price reductions, potentially improving affordability for patients undergoing cancer treatment.
The revised prices form part of the government’s efforts to monitor medicine prices and make essential medicines more accessible to the public. The NPPA is responsible for implementing pharmaceutical pricing policies and monitoring the prices of regulated medicines in India.
List to Be Updated as Manufacturers Submit Prices
The NPPA has stated that the list will be updated as manufacturers submit revised prices for non-scheduled anti-cancer drugs. This process is expected to provide updated pricing information as additional manufacturers report their revised rates.
Patients, caregivers and healthcare providers can refer to the official NPPA notifications to check the applicable prices of individual medicine brands.
The revised MRPs are relevant for patients and families managing the often substantial expenses associated with cancer treatment. However, the actual savings will depend on the specific medicine, brand and revised price applicable to each product.
Focus on Medicine Affordability
Cancer treatment can involve significant expenditure on medicines, diagnostic tests, hospitalisation and other medical services. Updates to medicine prices can therefore be important for patients seeking to manage treatment costs.
The latest NPPA announcement highlights the role of pharmaceutical price monitoring in improving transparency and helping consumers access reliable information about medicine prices.
Patients are advised to consult their doctors or pharmacists before making any changes to prescribed medicines and to verify revised prices through official government notifications.
The updated list of 543 anti-cancer medicine brands marks an important development in pharmaceutical pricing, with the revised MRPs scheduled to become effective from November 9, 2026.
Official source: National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, Government of India.